Latest filing published 18 Feb 2021 for bluebird bio, Inc., €12k.
Filing timeline
BuySaleInsider track record
Katy Burnett: trading record in brief
Katy Burnett appears in our data through filings on bluebird bio, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 3 December 2020 to 17 February 2021.
Every open-market trade on record is a sale: 2 sales worth €17k. Other entries cover 2 share grants. In 2021 alone, the filings show no purchases and 1 sale.
Most recently, on 18 February 2021, the filings show an open-market sale worth €12k in bluebird bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Katy Burnett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 518 shares@ US$28.1672.1% of flowCommon StockSEC:0001562180-21-001276:2
- 2,000 shares0Common StockSEC:0001562180-21-001276:0
- 1,427 shares0Common StockSEC:0001562180-21-001276:1
- 123 shares@ US$46.0868100.0% of flowCommon StockSEC:0001562180-20-007083:0
4 of 4 declarations
